Filing Details

Accession Number:
0001209191-12-042837
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-08-22 13:45:57
Reporting Period:
2012-08-13
Filing Date:
2012-08-22
Accepted Time:
2012-08-22 13:45:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1003642 Impax Laboratories Inc IPXL Pharmaceutical Preparations (2834) 650403311
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1245365 Nigel Fleming C/O Impax Laboratories, Inc.
30831 Huntwood Avenue
Hayward CA 94544
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-08-13 6,000 $6.55 7,999 No 4 M Direct
Common Stock Acquisiton 2012-08-20 6,000 $6.55 13,999 No 4 M Direct
Common Stock Disposition 2012-08-20 6,000 $23.99 7,999 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2012-08-13 6,000 $0.00 6,000 $6.55
Common Stock Stock Option (Right to Buy) Disposition 2012-08-20 6,000 $0.00 6,000 $6.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
30,000 2019-05-20 No 4 M Direct
24,000 2019-05-20 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
  2. The option became exercisable in three equal annual installments beginning on May 20, 2010, which was the first anniversary of the date on which the option was granted.